Delivery Order SPE2DR25D3802-SPE2DR26F6VCV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 6, 2026, for the supply of Atomoxetine HCL 40 mg capsules (30-count units) with a ceiling value of $2,616.84. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 7, 2026, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. The contract supports the federal government's pharmaceutical supply requirements,...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.00 to AmerisourceBergen Drug Corp for Atomoxetine HCL 80 mg capsules (30-count units) with a firm fixed price structure. The award, issued on September 19, 2025, is set to be completed by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract with no small business restrictions. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Atomoxetine HCL 25 mg capsules in 30-count quantities, with a contract ceiling value of $2,955.73 and an ultimate completion date of December 9, 2025. This non-set-aside delivery order represents a competitively awarded purchase executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.53 to AmerisourceBergen Drug Corp for Atomoxetine HCL 80 mg capsules (30-count) on December 17, 2025, with completion due by December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded competitively. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.14 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 18 mg capsules (30-count) with an ultimate completion date of May 7, 2025. This non-set-aside contract employs firm fixed-price terms and represents a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 18 mg capsules (30-count) with a ceiling value of $1,128.46. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value pharmaceutical supply...
- The Defense Logistics Agency awarded a $215,340 firm fixed price delivery order to Amerisourcebergen Drug Corporation for atomoxetine hydrochloride 40mg capsules. Under this contract, Amerisourcebergen will deliver 30 capsules of this pharmaceutical product to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Department of Defense's medical supply needs. As a leading pharmaceutical distributor, Amerisourcebergen routinely supports the Defense Logistics Agency's...
- SPE2DR25D3802Indefinite Delivery Contract
- SPE2DR25D3802-SPE2DR26F6VCVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,429.65 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 40 mg capsules (30-count units) on January 13, 2026, with completion targeted for January 14, 2026. The award was made on a non-competitive, firm fixed-price basis and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's parent company's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates Cencora, Inc.'s established capability to efficiently fulfill government pharmaceutical procurement requirements across various federal medical institutions, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/12/26 |